Speciality Medicines Limited
Indian Pharmaceutical Exporter ยท Advanced Oncology Specialist ยท $345.1K Total Trade ยท DGFT Verified
Speciality Medicines Limited is an Indian pharmaceutical exporter with a total trade value of $345.1K across 6 products in 2 therapeutic categories. Based on 76 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Pembrolizumab ($159.1K), Olaparib ($76.4K), Ustekinumab ($46.8K).
Speciality Medicines Limited โ Export Portfolio & Destination Treemap

Who is Speciality Medicines Limited? โ Company Overview & Market Position
Speciality Medicines Limited, established on February 5, 2021, is a public limited company headquartered in Ahmedabad, Gujarat, India. The company is registered under the Corporate Identification Number (CIN) U85300GJ2021PLC120022. As of March 31, 2023, Speciality Medicines Limited reported an annual revenue of approximately $2.8 million USD and a net profit of $264,620 USD. The company employs a dedicated team of 17 professionals committed to delivering high-quality pharmaceutical products. Speciality Medicines Limited specializes in the marketing and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, focusing on complex and chronic medical conditions. The company's product portfolio spans therapeutic areas such as oncology, immunology, neurology, and rare diseases.